Neurochem Res 45(7):14611480 Erritzoe D, Godlewska BR, Rizzo G et al (2023) Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge
Triple agonists have limited cardiovascular outcome data currently available, though metabolic parameters suggest potential benefits
Many patients prescribed GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or liraglutide (Victoza, Saxenda) notice changes in their bowel habits
Recent Post Related Post Category
At Mohip Dental & Associates in Wellington, FL, we have seen a noticeable uptick in patients reporting dry mouth, increased tooth sensitivity, gum irritation, and bad breath after starting GLP-1 therapy
These drugs can improve metabolic health, reducing inflammation and insulin resistance, which are risk factors for CRC